These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24351500)

  • 1. Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence base.
    Brew IF; Butt C; Wright N
    Br J Gen Pract; 2013 Dec; 63(617):e842-51. PubMed ID: 24351500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
    Hartwell D; Jones J; Baxter L; Shepherd J
    Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated interferon-α2a and ribavirin versus pegylated interferon-α2b and ribavirin in chronic hepatitis C : a meta-analysis.
    Flori N; Funakoshi N; Duny Y; Valats JC; Bismuth M; Christophorou D; Daurès JP; Blanc P
    Drugs; 2013 Mar; 73(3):263-77. PubMed ID: 23436591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
    Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J
    Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C, mental health and equity of access to antiviral therapy: a systematic narrative review.
    Hepworth J; Bain T; van Driel M
    Int J Equity Health; 2013 Nov; 12():92. PubMed ID: 24245959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic evaluation of pegylated interferon plus ribavirin for treatment of chronic hepatitis C in Thailand: genotype 1 and 6.
    Kapol N; Lochid-Amnuay S; Teerawattananon Y
    BMC Gastroenterol; 2016 Aug; 16(1):91. PubMed ID: 27492396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon alpha (pegylated and non-pegylated) and ribavirin for the treatment of mild chronic hepatitis C: a systematic review and economic evaluation.
    Shepherd J; Jones J; Hartwell D; Davidson P; Price A; Waugh N
    Health Technol Assess; 2007 Mar; 11(11):1-205, iii. PubMed ID: 17346498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in treatment paradigm in people who previously injected drugs with chronic hepatitis C in the era of direct-acting antiviral therapy.
    Wong GL; Chan HL; Loo CK; Hui YT; Fung JY; Cheung D; Chung C; Chim AM; Wong VW;
    J Gastroenterol Hepatol; 2019 Sep; 34(9):1641-1647. PubMed ID: 30707777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus.
    Iorio A; Marchesini E; Awad T; Gluud LL
    Cochrane Database Syst Rev; 2010 Jan; (1):CD004888. PubMed ID: 20091566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients.
    Chung WJ
    Clin Mol Hepatol; 2012 Sep; 18(3):268-71. PubMed ID: 23091806
    [No Abstract]   [Full Text] [Related]  

  • 12. Personality disorders do not affect treatment outcomes for chronic HCV infection in Spanish prisoners: the Perseo study.
    Marco A; Antón JJ; Trujols J; Saíz de la Hoya P; de Juan J; Faraco I; Caylà JA;
    BMC Infect Dis; 2015 Aug; 15():355. PubMed ID: 26286450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANTIVIRAL TREATMENT OF HEPATITIS C IN SERBIAN PRISON SETTING: MEDICAL TREATMENT OUTCOMES AND PATIENTS' ADHERENCE.
    Simonović Babić J; Bojović K; Delić D; Katanić N; Mitrović N; Malinić J
    Med Pregl; 2016; 69(3-4):85-91. PubMed ID: 27506095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Addicts with chronic hepatitis C: difficult to reach, manage or treat?
    Zanini B; Benini F; Pigozzi MG; Furba P; Giacò E; Cinquegrana A; Fasoli M; Lanzini A
    World J Gastroenterol; 2013 Nov; 19(44):8011-9. PubMed ID: 24307794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient adherence to antiviral treatment for chronic hepatitis B and C: a systematic review.
    Lieveld FI; van Vlerken LG; Siersema PD; van Erpecum KJ
    Ann Hepatol; 2013; 12(3):380-91. PubMed ID: 23619254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. District general hospital networks can provide safe and effective hepatitis C treatment: results of a 5-year audit.
    Hydes T; Allen H; Al-Shamma S; Hovell C; Sharer NM; Williams EJ
    Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):942-7. PubMed ID: 23510967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of efficacy of peginterferon and ribavirin combination therapy for chronic hepatitis C among Korean, Caucasian and other Asians].
    Kim KA
    Korean J Gastroenterol; 2012 Nov; 60(5):273-4. PubMed ID: 23311002
    [No Abstract]   [Full Text] [Related]  

  • 18. Systematic review: peginterferon vs. standard interferon in the treatment of chronic hepatitis C.
    Zaman A; Fennerty MB; Keeffe EB
    Aliment Pharmacol Ther; 2003 Oct; 18(7):661-70. PubMed ID: 14510739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis.
    Udina M; Castellví P; Moreno-España J; Navinés R; Valdés M; Forns X; Langohr K; Solà R; Vieta E; Martín-Santos R
    J Clin Psychiatry; 2012 Aug; 73(8):1128-38. PubMed ID: 22967776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
    Koretz RL; Pleguezuelo M; Arvaniti V; Barrera Baena P; Ciria R; Gurusamy KS; Davidson BR; Burroughs AK
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD003617. PubMed ID: 23440791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.